Strategies for global market access and patient delivery

Achieving global market access for advanced therapies depends on navigating heterogeneous regulatory frameworks, aligning value communication with payer expectations, and building delivery pathways that protect product integrity. This fireside chat explores decision frameworks and operational models that support international launch planning and consistent patient access.

Key takeaways:

• Compare regulatory and access requirements across priority global markets
• Define evidence and value demonstration needs that align with payer expectations
• Prioritize launch sequencing and access pathways based on feasibility and impact
• Strengthen distribution and cold chain models to ensure reliable patient delivery
• Assess organizational capabilities needed to support global expansion